Multiple Ascending Dose of BMS-911543

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this first in human study is to determine if BMS-911543 is safe and tolerable in subjects with symptomatic intermediate-1, intermediate-2 or high risk myelofibrosis to permit clinical testing at the Maximum Tolerated Dose or at a Clinically Active Dose, and to determine if BMS-911543 will demonstrate efficacy in symptomatic myelofibrosis.
Epistemonikos ID: b4f966818b01cffd9969cc6229324cbf82963279
First added on: May 06, 2024